newsfilter
← Latest News
GlobeNewswire·

Scopus BioPharma Expands Immunotherapy Pipeline with Acquisition of Olimmune

Transaction Creates Global Leader in Oligonucleotide Cancer Therapeutics Combined Assets Target Broad Range of Hematological Malignancies and Solid Tumors NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: "SCPS"),